We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+25.5%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$5.64B
AUM Growth
+$763M
Cap. Flow
-$277M
Cap. Flow %
-4.92%
Top 10 Hldgs %
23.75%
Holding
2,653
New
149
Increased
768
Reduced
1,024
Closed
109

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$6.19M
2
ABBV icon
AbbVie
ABBV
+$5.01M
3
DXCM icon
DexCom
DXCM
+$4.28M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.01M
5
PG icon
Procter & Gamble
PG
+$3.96M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$53.5M
2
CSCO icon
Cisco
CSCO
+$10.3M
3
AGN
Allergan plc
AGN
+$8.8M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$7.52M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$7M

Sector Composition

Rank Sector Weight
1 Technology 24.07%
2 Healthcare 14.46%
3 Financials 11.96%
4 Consumer Discretionary 10.97%
5 Communication Services 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LTHM
1601
DELISTED
Livent Corporation
LTHM
$276K ﹤0.01%
44,740
-635
-1% -$4K
DCH
1602
Dauch Corp
DCH
$1.61B
$275K ﹤0.01%
36,215
+303
+0.8% +$1.75K
INVA icon
1603
Innoviva
INVA
$1.5B
$275K ﹤0.01%
19,673
+2,506
+15% +$34.1K
PRIM icon
1604
Primoris Services
PRIM
$4.35B
$274K ﹤0.01%
15,447
+2,152
+16% +$33.9K
AMPH icon
1605
Amphastar Pharmaceuticals
AMPH
$858M
$274K ﹤0.01%
12,201
– –
INN
1606
Summit Hotel Properties
INN
$656M
$273K ﹤0.01%
46,121
+16,085
+54% +$90.7K
ADPT icon
1607
Adaptive Biotechnologies
ADPT
$3.89B
$273K ﹤0.01%
5,650
+1,861
+49% +$67.9K
TVTX icon
1608
Travere Therapeutics
TVTX
$5.79B
$272K ﹤0.01%
13,339
– –
ATRA icon
1609
Atara Biotherapeutics
ATRA
$83.1M
$272K ﹤0.01%
747
+136
+22% +$34.4K
HOUS
1610
DELISTED
Anywhere Real Estate
HOUS
$272K ﹤0.01%
36,642
+443
+1% +$2.29K
KURA icon
1611
Kura Oncology
KURA
$896M
$271K ﹤0.01%
16,647
+6,447
+63% +$93K
RETA
1612
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$271K ﹤0.01%
1,736
-5,144
-75% -$782K
VIE
1613
DELISTED
Viela Bio, Inc. Common Stock
VIE
$271K ﹤0.01%
6,252
+4,243
+211% +$192K
SNEX icon
1614
StoneX
SNEX
$8.05B
$270K ﹤0.01%
24,827
– –
VRTS icon
1615
Virtus Investment Partners
VRTS
$1.12B
$269K ﹤0.01%
2,315
+57
+3% +$5.34K
UCTT
1616
Ultra Clean Holdings
UCTT
$4.21B
$269K ﹤0.01%
11,887
– –
GTHX
1617
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$269K ﹤0.01%
11,087
– –
OMER icon
1618
Omeros
OMER
$1.26B
$268K ﹤0.01%
18,238
+2,993
+20% +$44.7K
SFL icon
1619
SFL Corp
SFL
$1.57B
$268K ﹤0.01%
28,823
+3,213
+13% +$32.1K
NP
1620
DELISTED
Neenah, Inc. Common Stock
NP
$267K ﹤0.01%
5,401
– –
VSTO
1621
DELISTED
Vista Outdoor Inc.
VSTO
$266K ﹤0.01%
18,434
– –
BGC icon
1622
BGC Group
BGC
$5.2B
$266K ﹤0.01%
97,085
+89,837
+1,239% +$249K
BDN
1623
Brandywine Realty Trust
BDN
$542M
$266K ﹤0.01%
24,411
+5,625
+30% +$57.9K
SBSI icon
1624
Southside Bancshares
SBSI
$979M
$265K ﹤0.01%
9,571
– –
LBRDK icon
1625
Liberty Broadband Class C
LBRDK
$5.07B
$265K ﹤0.01%
2,138
-421
-16% -$52.8K
63 64
65
66 67

Similar funds

RM
Rudius Management New York $358M AUM 12.23% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
KLWA
Kelly Lawrence W & Associates Pasadens, California $360M AUM 16.9% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s Q2 2020 Portfolio in Review

As of Q2 2020, Metropolitan Life Insurance Company (MetLife) held 2,653 positions worth $5.64B, up 16% from $4.87B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $277M in Q2 2020, closing 109 positions and reducing 1,024 holdings. Its most notable exit was Allergan plc, an estimated $8.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Otis Worldwide worth $3.26M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2020 buy was Otis Worldwide: 57,385 shares worth $3.26M.
  • Metropolitan Life Insurance Company (MetLife) added most to Amazon in Q2 2020, an estimated $6.19M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $53.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Allergan plc in Q2 2020, selling an estimated $8.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $5.64B portfolio in Q2 2020.
  • Metropolitan Life Insurance Company (MetLife) opened 149 new positions and closed 109 in Q2 2020.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 16% quarter-over-quarter to $5.64B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2020, filed 14 Aug 2020.